Arturo LoAIza-Bonilla, MD MSEd
LightNews LightNews
banner
drbonillaonc.bsky.social
Arturo LoAIza-Bonilla, MD MSEd
@drbonillaonc.bsky.social
1.1K followers 850 following 33 posts
Co-founder @MassiveBio | Chief Hem/Onc @mystlukes | Using #tech #AI & #genomics to fight cancer at global scale 🌎 🚀 🧬 🖥️ - My Opinions only
Posts Replies Media Videos
Reposted by Arturo LoAIza-Bonilla, MD MSEd
oncodaily.bsky.social
Solving the Clinical Trial Enrollment Paradox Using AI and Big Data - Arturo LoAIza-Bonilla

@drbonillaonc.bsky.social

oncodaily.com/voices/artur...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Arturo LoAIza-Bonilla: Solving the Clinical Trial Enrollment Paradox Using AI and Big Data - OncoDaily
Arturo LoAIza-Bonilla: Solving the Clinical Trial Enrollment Paradox Using AI and Big Data / Arturo Loaiza-Bonilla, ASCO, cancer, OncoDaily, Oncology
oncodaily.com
September 19, 2025 at 6:12 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
ai.nejm.org
Perspective by Arturo Loaiza-Bonilla, MD, MSEd, FACP, and Scott Penberthy, PhD : Harnessing Moravec’s Paradox in Health Care: A New Era of Collaborative Intelligence nejm.ai/4jSWaVV

@drbonillaonc.bsky.social #AI #MedSky #MLSky
Figure 1. Moravec’s Paradox in Health Care.
June 3, 2025 at 2:10 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
jrgralow.bsky.social
#asco25 joint @ascocancer.bsky.social @myesmo.bsky.social session on “Biomarker-driven Therapeutics: Translating Innovation into Practice” @drbonillaonc.bsky.social
June 3, 2025 at 2:35 PM
drbonillaonc.bsky.social
Red lens sunglasses can enhance contrast and depth perception, may also reduce eye fatigue by filtering certain wavelengths and improving visual comfort. After so much screen time in preparation for #ASCO25 this really helps! See you in Chicago!! @ASCO @mystlukes @americancancersoc.bsky.social
May 29, 2025 at 9:30 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
oncodaily.bsky.social
Performance Evaluation of an AI-powered System for Clinical Trial Eligibility Using mCODE Data Standards - Yan Leyfman
@yleyfman.bsky.social
@drbonillaonc.bsky.social
@massive-bio.bsky.social

oncodaily.com/blog/yan-ley...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AI
Yan Leyfman: Performance Evaluation of an AI-powered System For Clinical Trial Eligibility Using mCODE Data Standards - OncoDaily
Yan Leyfman: Performance Evaluation of an AI-powered System For Clinical Trial Eligibility Using mCODE Data Standards / and Cagatay Culcuoglu, Arturo
oncodaily.com
May 29, 2025 at 8:25 PM
drbonillaonc.bsky.social
ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics dailynews.ascopubs.org/do/asco-esmo...
ASCO Daily News
dailynews.ascopubs.org
May 17, 2025 at 10:00 PM
drbonillaonc.bsky.social
Filming day at St. Luke’s! 🎥
From clinical trials to AI-powered care, we’re showcasing how we fight cancer with heart and innovation. 🚀

16 hospitals.
Robotic surgery.
Advanced radiation.
Multiomics + bi-specifics.
The most wired health system in the U.S.
All for you.

#StLukesProud
May 9, 2025 at 6:21 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
n8pennell.bsky.social
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.... #ASCO25 @drbonillaonc.bsky.social
May 2, 2025 at 8:02 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
oncodaily.bsky.social
How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support - Arturo LoAIza-Bonilla
@drbonillaonc.bsky.social

oncodaily.com/blog/arturo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AI #ASCO25
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support - OncoDaily
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support / AI, Arturo Loaiza-Bonilla, ASCO,
oncodaily.com
May 2, 2025 at 9:15 PM
drbonillaonc.bsky.social
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10....
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology
Artificial intelligence (AI) is transforming multidisciplinary oncology at an unprecedented pace, redefining how clinicians detect, classify, and treat cancer. From earlier and more accurate diagnoses...
ascopubs.org
May 2, 2025 at 8:56 PM
drbonillaonc.bsky.social
Thrilled to see my latest article featured in the Spring 2025 issue of llOncolytics Today! 🌟 “Closing the Gaps in Oncology: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support”
#ASCO25.

See you in Chicago!

#PrescreeningHubs
April 30, 2025 at 6:55 AM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
dshaywitz.bsky.social
Moravec’s paradox also discussed in context of AI & healthcare by @pmarca.tweet.pub in recent thoughtful @a16z.bsky.social pcast, as I wrote about here: timmermanreport.com/2025/02/the-...
April 24, 2025 at 7:49 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
erictopol.bsky.social
A good discussion of Moravec's paradox in healthcare
@NEJM_AI
ai.nejm.org/doi/full/10....
Harnessing Moravec’s Paradox in Health Care: A New Era of Collaborative Intelligence
Artificial intelligence excels at complex data analytics, yet struggles with nuanced, sensorimotor tasks that humans perform almost effortlessly — a dichotomy encapsulated by Moravec’s paradox. By ...
ai.nejm.org
April 24, 2025 at 4:58 PM
drbonillaonc.bsky.social
Thrilled! Our @ai.nejm.org NEJM AI perspective “Harnessing Moravec’s Paradox in Health Care” - is now live. Grateful for brilliant co-author & friend Scott Penberthy (@scottpenberthy) of @GoogleCloud. Onward to truly collaborative intelligence! 🔗 ai.nejm.org/stoken/defau...
April 24, 2025 at 5:27 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
oncodaily.bsky.social
Full day of CME discussing the top research from ASCOGI25 - @drbonillaonc.bsky.social
@ascocancer.bsky.social

oncodaily.com/url/269641

#OncoDaily #Oncology #Cancer #Health #Medicine #ASCOGI25
Arturo LoAIza-Bonilla: Full day of CME discussing the top research from ASCOGI25 - OncoDaily
Arturo LoAIza-Bonilla: Full day of CME discussing the top research from ASCOGI25 / American Society of Clinical Oncology, Arturo Loaiza-Bonilla, ASCO,
oncodaily.com
April 8, 2025 at 7:34 AM
drbonillaonc.bsky.social
www.cancernetwork.com/view/investi... - Dr. Regina Barzilay PhD, Ketan Badani MD FRCS and I share some insights on it’s future implementation in cancer care | St. Luke's University Health Network | Massive Bio | Massachusetts Institute of Technology | Mount Sinai Health System #AI #cancer
Investigating the Emergence of Artificial Intelligence on Oncologic Practice
As artificial intelligence has arrived in the oncology field, experts discuss how this new technology can have implications for transforming clinical practice.
www.cancernetwork.com
March 15, 2025 at 11:33 PM
drbonillaonc.bsky.social
Great representation of @mystlukes at @LmsaNational NE 2025 meeting!! Appreciate the invitation to hopefully inspire future generations of physicians. Even better when Dr. Israel Zighelboim as faculty! #stlukesproud @MassiveBio | @TUMedResearch @TempleUniv #AI
March 8, 2025 at 7:14 PM
drbonillaonc.bsky.social
LIVE today discussing the urgent challenges in cancer research and clinical trials due to funding cuts. AI, innovation, & collaboration are key to overcoming these obstacles and driving progress in the field. @MassiveBio
Tune in now for key insights! 🎥👇
📺 Watch live: www.youtube.com/watch?v=ar5q...
February 12, 2025 at 4:56 PM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
massive-bio.bsky.social
NIH funding cuts threaten clinical trials and patient access to life-saving treatments. Our Co-Founder & CMO, @drbonillaonc.bsky.social, shares how we can adapt and innovate.

Read the open letter 👉 bit.ly/3CyOtnP

#Cancer #cancerclinical #clinicaltrials #OpenLetter
An Open Letter to Cancer Centers, Research Institutions, and the Broader Oncology Community
February 2025 Dear Colleagues, In light of the recent developments regarding the The National Institutes of Health’s (NIH) abrupt reduction of indirect cost rates—from historical levels approaching 50...
bit.ly
February 10, 2025 at 10:50 AM
Reposted by Arturo LoAIza-Bonilla, MD MSEd
massive-bio.bsky.social
Massive Bio remains committed to accelerating cancer research and expanding clinical trial access amid the uncertainty surrounding recent NIH funding cuts.

The mission to ensure equitable access to innovative cancer care is more critical than ever.

Read the full press release: bit.ly/3CIRXEg
February 11, 2025 at 2:14 PM
drbonillaonc.bsky.social
www.onclive.com/view/artific... This is a long format grand rounds video for OncLive where I share about the advent of #ArtificialIntelligence in #CancerCare and #ClinicalTrials - hope you find it interesting @massive-bio.bsky.social
Artificial Intelligence in Cancer Care and Clinical Trials
Arturo Loaiza-Bonilla, MD, discusses artificial intelligence in cancer care and clinical trials.
www.onclive.com
January 28, 2025 at 3:23 PM
drbonillaonc.bsky.social
#AI #LLM #medicaleducation www.medscape.com/viewarticle/...
The Rise of Large Language Models in Medicine: The Next Frontier
In his latest column, Arturo Loaiza-Bonilla, MD, MSEd, explores the latest on large language models in medicine and the new era of medical training and practice.
www.medscape.com
January 24, 2025 at 7:45 PM
drbonillaonc.bsky.social
Proud to be in California at the AMA/RUC meeting, representing American Society of Clinical Oncology (ASCO) and all U.S. oncology practices to champion equitable access and fair reimbursement for lifesaving cancer therapies. Thank you to our dedicated ASCO staff for your hard work, and to SLUHN!
January 15, 2025 at 6:26 PM
drbonillaonc.bsky.social
Proudest moment for Massive Bio on being recognized by The White House Cancer Moonshot for our efforts in helping cancer patients to transform access clinical trials with our AI-enabled platform and scalable pre-screening hubs. Massive thank you to team and all our partners who make this possible!!
January 15, 2025 at 4:39 PM
drbonillaonc.bsky.social
Fascinating fire chat with @bryan_johnson during our Scrub Capital mtg. Kudos to being bold investing in efforts to understand longevity, epigenetic, biomarkers, aging clocks, human physiology. At @MassiveBio we are taking also a bold innovative approach to transform clinical trials & research!! 🚀
January 11, 2025 at 8:09 AM